在疫情四起的時刻,羅氏決不會坐以待斃,為了保證羅氏快篩的可信度,將羅氏快篩送至WHO世界衛生組織進行變種病毒認證,也得到羅氏快篩可偵測變異病毒的認可,在人人自危的狀況下,可信賴的羅氏快篩是您防疫的最佳守門員! 羅氏與康誠必為企業做到最好的防護。
No impact of the following virus variants has been observed on the Roche SARS- CoV-2 Rapid Antigen Testing Portfolio:
Country first reported in | WHO Nomenclature |
WHO Classification |
Lineage | Country first reported in | WHO Nomenclature |
WHO Classification |
Lineage | |
UK | Alpha | VOC | B.1.1.7 | USA | Epsilon | VUM | B.1.429 | |
South Africa | Beta | VOC | B.1.351 | Iota | VUM | B.1.526 | ||
Japan/Brazil | Gamma | VOC | P.1 | B.1.526.2 | ||||
India | Delta | VOC | B.1.617.2 | Egypt | N/A | C.36 | ||
Peru | Lambda | VOI | C.37 | Colombia | Mu | B.1.621 | ||
Colombia | Mu | VOI | B.1.621 | Brazil | Zeta | P.2 | ||
India | Kappa N/A Delta Plus Delta Plus Delta Plus |
VUM | B.1.617.1 B.1.617.3 AY.1 AY.2 AY.3 |
Multiple countries | Eta | VUM | B.1.525 | |
Phillipines | Theta | P.3 | ||||||
UK | A.23.1 | |||||||
France | B.1.616 | |||||||
USA | Epsilon | VUM | B.1.427 | Russia | AT.1 |
VOC: Variant of Concern, VOI: Variant of Interest, VUM: Variant Under Monitoring
As emerging virus variants are identified, we commit to continuously monitor them independently and in collaboration with our partner, SD Biosensor.
References
- SD Biosensor, Analytical Study (in-silico testing): Q COVID-19 Ag_SARS-CoV-2 Variants in-silico analysis_Rev.03
- SD Biosensor, Analytical Study (wet testing): SARS-CoV-2 Variants LOD test as recombinant protein_Rev.06
Published by Roche Diagnostics International Ltd. | 6343 Rotkreuz, Switzerland | © 2021 | www.roche.com